Type I IFN signaling along with increased cell cycling in the post-septic environment contribute to this compositional change, which may have direct implications for therapeutic intervention to enhance CD8 T cell function in immunocompromised sepsis survivors. This evidence concerns the gene CD8A and Sepsis.